The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the µ opioid receptor-Reference-Cited by-同舟云学术

The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the µ opioid receptor

Published:2023-01 Issue: Volume:159 Page:170901
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Mizuguchi Takaaki^ORCID,Miyano Kanako,Yamauchi Risa,Yoshida Yuki,Takahashi Hideki,Yamazaki Ami,Ono Haruka,Inagaki Miku,Nonaka Miki,Uezono Yasuhito,Fujii Hideaki^ORCID

Funder

Takeda Science Foundation

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference49 articles.

1. Emerging paradigms in GPCR allostery: implications for drug discovery;Wootten;Nat. Rev. Drug Discov.,2013

2. Allosteric modulators of sigma-1 receptor: a review;Vavers;Front. Pharmacol.,2019

3. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications;Burford;Br. J. Pharmacol.,2015

4. Pharmacological and clinical profiles of a novel calcimimetic, evocalcet (ORKEDIA ®);Tokunaga;Nihon Yakugaku Zasshi,2019

5. Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism;Miyazaki;Bioorg. Med. Chem. Lett.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous opiates and behavior: 2023;Peptides;2024-09

2. IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders;Pharmacological Research;2024-01

3. Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses;Exploration of Targeted Anti-tumor Therapy;2023-10-25